Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium

Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium

Human pluripotent stem cells (hPSCs) are a promising source of autologous endothelial progenitor cells (EPCs) that can be used for the treatment of vascular diseases. However, this kind of treatment requires a large amount of EPCs. Therefore, a highly efficient, robust, and easily reproducible diffe...

Full description

Bibliographic Details
Main Authors: Simon Farkas, Pavel Simara, Daniela Rehakova, Lenka Veverkova, Irena Koutna
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
hiPSC
hESC
hPSC
mesoderm
endothelial progenitors
differentiation
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2020.00309/full

Internet

https://www.frontiersin.org/article/10.3389/fcell.2020.00309/full

Similar Items